Glanbia stock

GL9 · Euronext Dublin · EUR

€20.14Change from previous close: +0.60%Absolute change: +€0.12

Close · November 16, 2026

Price history

+36.73% over the period

1 year: from €14.73 (November 17, 2025) to €20.14 (November 16, 2026), +36.73%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 2026€20.14
October 30, 2026€20.86
September 30, 2026€19.65
August 31, 2026€22.14
July 31, 2026€22.98
June 30, 2026€24.46
May 29, 2026€20.86
April 30, 2026€19.78
March 31, 2026€16.95
February 27, 2026€17.50
January 30, 2026€16.23
December 31, 2025€14.59
November 28, 2025€14.79
November 17, 2025€14.73

At a glance

  • The company

    Produces sports nutrition and lifestyle nutrition products, dairy and non-dairy nutritional ingredients, and vitamin premixes

  • Latest results

    Quarter to June 30, 2026

TickerLandia's take on Glanbia

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low€14.09
52-wk high€25.10

−19.76% from the 52-week high

Analysts · 10 analysts

Average target€23.98+19.05% vs. price

Buy 5 · Hold 3 · Sell 2 · Buy

TickerLandia Fingerprint: Glanbia

Compared with similar companies: high risk.

Financials and price compared with 58 companies in the packaged foods industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Glanbia is in line with similar companies

Glanbia's P/E (trailing 12 months): 24.1, in line with the median of a group of 10 similar companies (25.0).

Compared with 10 similar companies

Glanbia's metrics compared with similar companies
MetricGlanbiaPosition in the groupBand
P/E (trailing 12 months)24.1Middle
Forward P/E13.0Middle
Operating margin9.6%Middle
ROE12.0%Middle
Debt/equity0.64Middle

Grey band: the middle half of the group; tick: the median; dot: Glanbia. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$2.08B

Latest quarter · Q2 2026

Net income

$153.8M

Latest quarter · Q2 2026

Quarterly net margin

7.4%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
€4.84B
P/E
24.1
EPS
€0.83
Volume
589.52K
Daily trading
€9.59M
Dividend yield
2.21%
Last ex-dividend on August 20, 2026

How Glanbia is changing

All results
  • Revenue fell 3.3% a year on average over the last 5 years

  • Operating margin rose from 4.8% to 8.9%

  • Profits turn into cash: free cash flow equal to 158% of net income

Returns

Glanbia returns with dividends

€1,000 invested in Glanbia 5 years ago, on November 16, 2021, would be worth €1,774 today with dividends reinvested: +77.37% in total, +12.15% per year. On price alone it would be €1,559 (+55.88%).

PeriodGlanbia€1,000 becomes
1 month−0.98%€990
6 months−1.18%€988
Year to date+38.04%€1,380
1 year+40.00%€1,400
3 years+41.67%€1,417
5 years+77.37%€1,774
10 years+61.46%€1,615

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Glanbia: technical analysis

Glanbia shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 18.9% below its all-time closing high (€24.84, July 3, 2026).

Trend
No clear trend
RSI (14 sessions)
49
Between 30 and 70
vs 200-session average
−0.40%

Active signals

  • Death cross: the 50-session average has crossed below the 200-session average.

Support and resistance

Price areas where Glanbia has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance€22.63+12.36%2 touches, last on September 9, 2026
  2. Resistance€22.03+9.38%4 touches, last on November 4, 2026
  3. Resistance€21.01+4.34%3 touches, last on October 15, 2026
  4. Last price€20.14
  5. Support€19.20−4.67%2 touches, last on November 9, 2026
  6. Support€18.64−7.43%3 touches, last on October 12, 2026
  7. Support€17.51−13.06%5 touches, last on April 10, 2026

Volatility and risk

Volatility (60 sessions, annualised)
43.9%
Largest fall in the last year
−24.88%

In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Glanbia: seasonality

Average monthly price change over 27 years

+3.0%Jan+1.7%Feb+1.5%Mar+1.6%Apr+2.9%May+1.0%Jun+0.9%Jul+1.2%Aug−0.2%Sep−0.5%Oct+0.0%Nov+2.7%Dec

Over the last 27 years, the strongest month for Glanbia has been January: +2.98% on average, positive in 14 years out of 26. The weakest has been October: −0.53% on average, positive in 13 years out of 27. November, the current month, has been positive in 14 years out of 26 (+0.01% on average).

Show chart data
MonthAverageMedianPositive years
January+2.98%+2.23%14 of 26
February+1.66%+4.48%20 of 27
March+1.49%−0.07%13 of 27
April+1.58%0.00%13 of 27
May+2.86%+1.46%16 of 27
June+1.00%−1.30%11 of 27
July+0.86%+2.19%18 of 27
August+1.24%+1.52%15 of 27
September−0.25%+0.32%14 of 27
October−0.53%−0.40%13 of 27
November+0.01%+0.71%14 of 26
December+2.75%+1.43%14 of 26

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Glanbia and its competitors

Athletes, gym users and everyday shoppers across the world make up the customer base of Glanbia plc, which reaches them through sports stores, supermarkets, drugstores, fitness centres and online platforms. The company develops sports and lifestyle nutrition products in powder, capsule, tablet, bar and ready-to-drink form, sold under brands including Optimum Nutrition, BSN, Isopure, Nutramino, think! and Amazing Grass.

Headquarters
Kilkenny, Ireland
Employees
4,963
Founded
1964
Chief executive
Hugh McGuire
Glanbia and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
GlanbiaGL9$5.35B9.6%24.1−1.18%
AAK AB (publ.)AAK$4.59B10.5%13.1−32.35%
EmmiEMMN$6.27B7.1%22.8+18.43%
Tate & LyleTATE$3.28B11.6%37.4+4.94%
Ebro FoodsEBRO$3.08B9.7%12.6+1.01%
Lerøy Seafood GroupLSG$2.77B4.8%35.3−0.22%

Same industry or related industries, similar size. Compare Glanbia with its competitors · Full profile